Skip to content
  • Instagram
logo The Onco Doc

Oncology, Reinvented for Tomorrow

Get Newsletter
  • Home
  • Blogs
  • Authors
Home » Continuing Medical Education (CME) » Page 2
Beyond the Hype: 5 AI Use Cases Pharma Marketers Are Piloting in 2025
Posted inPharma Marketing

Beyond the Hype: 5 AI Use Cases Pharma Marketers Are Piloting in 2025

Posted by OncoDoc September 6, 2025
Abstract The pharmaceutical industry, especially within the highly specialized field of oncology in the US,…
Read More
Can Precision Marketing with AI Revolutionize Pharma Like Precision Medicine Transformed Oncology?
Posted inPharma Marketing

Can Precision Marketing with AI Revolutionize Pharma Like Precision Medicine Transformed Oncology?

Posted by OncoDoc September 5, 2025
Abstract Precision Medicine has fundamentally reshaped oncology, moving beyond one-size-fits-all treatments to deliver highly targeted…
Read More
Binge-Worthy Insights: Is Your Pharma Engagement as Compelling as Netflix? What Oncologists Really Want
Posted inPharma Marketing

Binge-Worthy Insights: Is Your Pharma Engagement as Compelling as Netflix? What Oncologists Really Want

Posted by OncoDoc September 4, 2025
Abstract In an era saturated with information and personalized digital experiences, healthcare professionals (HCPs), particularly…
Read More
Beyond Remission: Are Pharma and Physicians Ready for the Long-Term Journey of Immunotherapy and Targeted Therapy Survivors?
Posted inPharma Marketing

Beyond Remission: Are Pharma and Physicians Ready for the Long-Term Journey of Immunotherapy and Targeted Therapy Survivors?

Posted by OncoDoc September 3, 2025
Abstract The advent of immunotherapy (IO) and targeted therapies (TT) has dramatically reshaped the landscape…
Read More
Are You Losing Doctors’ Attention? Re-Engage with AI in Oncology Marketing
Posted inPharma Marketing

Are You Losing Doctors’ Attention? Re-Engage with AI in Oncology Marketing

Posted by OncoDoc September 2, 2025
Abstract The oncology landscape in the US is rapidly evolving, marked by scientific breakthroughs, an…
Read More
Why 70% of Oncology Drug Launches Falter? How AI-Powered Digital Marketing Platforms, like Hidoc, are Rewriting the Rules for US Pharma
Posted inPharma Marketing

Why 70% of Oncology Drug Launches Falter? How AI-Powered Digital Marketing Platforms, like Hidoc, are Rewriting the Rules for US Pharma

Posted by OncoDoc September 1, 2025
Abstract  The oncology drug development landscape is notoriously challenging, with a staggering 70% of new…
Read More
Beyond the Scroll: Can Unnati Drive Unprecedented Oncology Awareness for US Pharma?
Posted inPharma Marketing

Beyond the Scroll: Can Unnati Drive Unprecedented Oncology Awareness for US Pharma?

Posted by OncoDoc August 30, 2025
Abstract In the complex and rapidly evolving US oncology market, driving effective awareness among Healthcare…
Read More
24/7 Engagement in Oncology: Can Pharma Brands Afford to Ignore MediBot?
Posted inPharma Marketing

24/7 Engagement in Oncology: Can Pharma Brands Afford to Ignore MediBot?

Posted by OncoDoc August 29, 2025
Abstract The modern oncology landscape is characterized by a relentless influx of complex scientific data…
Read More
From CME to Competitive Advantage: Can Unnati Transform Oncology Brand Promotions in the AI Era?
Posted inPharma Marketing

From CME to Competitive Advantage: Can Unnati Transform Oncology Brand Promotions in the AI Era?

Posted by OncoDoc August 28, 2025
Abstract The oncology landscape is characterized by relentless innovation, yet pharmaceutical brand promotion often struggles…
Read More
The journey to outperforming in oncology medico-marketing is not a matter of simply adopting new technologies, but of embracing a new philosophy
Posted inPharma Marketing

Is Unnati the Key to Upskilling Oncologists at Scale? A New Era for Pharma Partnerships

Posted by OncoDoc August 26, 2025
Abstract The accelerating pace of innovation in oncology presents a monumental challenge: how to effectively…
Read More

Posts pagination

Previous page 1 2 3 4 … 6 Next page

Stay informed. Stay ahead.
Get the latest oncology
insights and pharma
marketing trends delivered
straight to your inbox.
Subscribe to our Newsletter!

India: Infedis Infotech LLP.
1st Floor, Office No 108, S No 557 A 1 CTS No
97, Suyog Center, Gultekdi, Pune, Maharashtra
For Queries/Grievances, Contact : V. Gadia
+91-9665017922
info@hidoc.co
LLP Identification Number : AAH-8647

Infedis Health Private Limited.
Suyog Center, Office No. 108, 1st Floor, Gultekdi, Pune, Maharashtra, India - 411037
CIN of the Company : U74999PN2018PTC175141

US : Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
+1 (415) 463-3094

CSR Policy

Copyright 2025 â€” The Onco Doc. All rights reserved.
Terms & Conditions - LLP |  Inc. |  Privacy Policy - LLP |  Inc. |  Account Deactivation
Scroll to Top